CALGARY, Feb. 19, 2019 /CNW/ - Middlefield Group is
pleased to announce the launch of a Exchange-Traded Funds ("ETFs")
platform that will provide investors with professional active
management within a cost-effective, investor-friendly structure.
The platform provides exposure to unique, actively managed
strategies on a lower cost basis which investors may have
difficulty replicating on their own or with passive investment
products. We are initially converting two successful
closed-end funds, Middlefield Healthcare & Life Sciences
Dividend Fund ("LS.UN") and REIT INDEXPLUS Income
Fund ("IDR.UN"), as approved by unitholders at special meetings
held on December 10, 2018. A
final prospectus dated February 12,
2019 has been filed with the securities regulatory
authorities in each province and territory in Canada.
Commencing today, Middlefield Healthcare & Life Sciences
ETF (new TSX ticker symbol: LS) and REIT INDEXPLUS ETF (new TSX
ticker symbol: IDR) begin trading as ETFs. The conversions to ETFs
were not taxable events for unitholders and units of the funds were
converted to units of the applicable ETF on a 1:1 basis with all
costs associated with the conversions being borne by the
Manager.
|
About Middlefield
Healthcare & Life Sciences ETF
|
|
Actively managed
portfolio of securities operating in or deriving a significant
portion of their earnings from products and services related to the
healthcare and life sciences industries
Monthly distribution
of $0.04167/unit
|
|
About Middlefield
REIT INDEXPLUS ETF
|
|
Low-cost exposure to
the real estate sector through a combination of indexing and active
portfolio management
Monthly distribution
of $0.065/unit
|
About Middlefield Group
Middlefield was established in
1979 and has approximately $4 billion
in assets under management. Middlefield is a Specialty Investment Manager
which creates investment products designed to balance risk and
return to meet the demanding requirements of Financial Advisors and
their clients. These financial products include Mutual Funds, ETFs,
Private and Public Resource Funds, Venture Capital Assets, TSX
Publicly Traded Funds and Real Estate Investment Funds and
Partnerships.
Certain statements in this press release may be viewed as
forward-looking statements. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs,
plans, intentions, projections, objectives, assumptions or future
events or performance (often, but not always, using words or
phrases such as "expects", "is expected", "anticipates", "plans",
"estimates" or "intends" (or negative or grammatical variations
thereof), or stating that certain actions, events or results "may",
"could", "would", "might" or "will" be taken, occur or be achieved)
are not statements of historical fact and may be forward-looking
statements. There are no assurances the funds can fulfill such
forward-looking statements and the funds do not undertake any
obligation to update such statements. Such forward-looking
statements are only predictions; actual events or results may
differ materially as a result of risks facing one or more of the
funds, many of which are beyond the control of the funds.
Commissions, trailing commissions, management fees and
expenses all may be associated with ETFs. Please read the
prospectus before investing. ETFs are not guaranteed, their values
change frequently and past performance may not be repeated.
SOURCE Middlefield Healthcare & Life Sciences ETF
